MARKETS
Markets

Waters And Labcorp To Expand Access To BD Onclarity HPV Assay

Oct 23, 2026 · 08:06 AM ET· updated 51m ago

Labcorp intends to be the first commercial laboratory to offer FDA-approved HPV testing with the BD Onclarity™ HPV Assay across clinician-collected and self-collected screening options in clinic, patient service center,

Share
Why It Matters

Waters and Labcorp will offer a new HPV cancer screening test. This shows the companies are expanding their healthcare services and reaching more patients.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.